SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-24-003523
Filing Date
2024-10-16
Accepted
2024-10-16 16:30:13
Documents
1
Group Members
BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LPCORMORANT PRIVATE HEALTHCARE FUND III, LPCORMORANT PRIVATE HEALTHCARE FUND IV, LPCORMORANT PRIVATE HEALTHCARE FUND V, LPCORMORANT PRIVATE HEALTHCARE GP III, LLCCORMORA

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G/A 189658
  Complete submission text file 0000929638-24-003523.txt   191940
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

IRS No.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Subject) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92480 | Film No.: 241374969
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)